{"mainPropery":{"diseaseId":12598,"diseaseName":"Familial partial lipodystrophy type Köbberling","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12598/familial-partial-lipodystrophy-type-kobberling","synonyms":["Familial partial lipodystrophy type 1","FPLD1","Familial partial lipodystrophy, Köbberling type"],"synonyms-with-source":[{"name":"Familial partial lipodystrophy type 1","source":"Orphanet"},{"name":"FPLD1","source":"Orphanet"},{"name":"Familial partial lipodystrophy, Köbberling type","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"OMIM","identifierId":"608600"},{"identifierType":"ORPHANET","identifierId":"79084"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases","source":"Orphanet"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/608600' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79084' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:608600' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":11193,"questionText":"What is Familial partial lipodystrophy type K&ouml;bberling?","answerText":"<strong>Familial partial lipodystrophy type K&ouml;bberling</strong> is a rare subtype of early-onset <a href=\"https://ghr.nlm.nih.gov/condition/familial-partial-lipodystrophy\" target=\"_blank\">familial partial lipodystrophy</a>&nbsp;(FPL), characterized by fat loss in the lower limbs and abnormal fat increase in other areas. The symptoms are similar to those seen in <a href=\"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=2348\" target=\"_blank\">familial partial lipodystrophy, Dunnigan type</a> (the most common type of FPL). &nbsp;However, only arms and legs have fat loss, and there is a normal or slightly increased fat distribution on the face, neck, and trunk, with excess of belly fat (central obesity).[12402][12403] Metabolic abnormalities including <a href=\"http://www.webmd.com/diabetes/type-2-diabetes-guide/insulin-resistance-syndrome\" target=\"_blank\">insulin resistance</a>, high blood pressure (<a href=\"https://medlineplus.gov/ency/article/000468.htm\" target=\"_blank\">hypertension</a>), and high levels of fat in the blood (<a href=\"http://www.webmd.com/cholesterol-management/familial-hypertriglyceridemia\" target=\"_blank\">hypertriglyceridemia</a>) have also been reported. This form of FPL has only been reported in women. Inheritance seems to be <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a>,  but the exact cause is not known.[12402][12403][12404][12405] Treatment includes medication for the metabolic problems, diet and exercises, and in some cases, surgical procedures.[12405]<br />","dateModified":"2016-10-20T14:33:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":11962,"relatedDiseaseName":"Familial partial lipodystrophy","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":58925,"abbreviatedInquiry":"I am diagnosed with familial partial lipodystrophy type Köbberling, but the medication is not helping.  I read about bypass gastric surgery for morbid obesity and I wonder is it will be a good treatment for me.","caseQuestions":[{"questionId":11194,"questionText":"Can K&ouml;bberling partial lipodystrophy be treated with a gastric bypass surgery?","answerText":"There are not many patients described with this subtype of lipodystrophy and therefore, treatment is still not well established.&nbsp; However, Roux-en-Y gastric bypass (RYGBP) is a recognized treatment for <a href=\"https://www.urmc.rochester.edu/highland/bariatric-surgery-center/questions/morbid-obesity.aspx\" target=\"_blank\">morbid obesity</a>, which reverses or prevents the main problems of the&nbsp;<a href=\"http://www.webmd.com/diabetes/type-2-diabetes-guide/insulin-resistance-syndrome\" target=\"_blank\">insulin resistance syndrome</a>, which is also a common finding in the partial lipodystrophy syndromes.[12405] As far as we know there are only a few reports about Roux-en-Y gastric bypass (RYGBP) surgery as a treatment for the metabolic problems associated with familial partial lipodystrophy.[12405] <br />\r\n<br />\r\nThe first reported case about the use of &nbsp;RYGBP\r\nto treat severe insulin resistance and hypertriglyceridemia\r\nassociated with partial lipodystrophy was about a 41-year-old woman with an unknown type of familiar partial lipodystrophy, &nbsp;who had severe\r\n<a href=\"http://www.webmd.com/diabetes/type-2-diabetes-guide/insulin-resistance-syndrome\" target=\"_blank\">insulin resistance</a>  and had\r\nfailed multiple treatments. Within a few days of surgery, her blood sugar levels and blood fat levels had  improved. &nbsp;She was able to have a pregnancy and delivered a healthy baby.&nbsp;<br />\r\n<br />\r\nOne report was about a 55-year-old a woman with familiar partial lipodystrophy (FPL) who was diagnosed as FPL type 1 (K&ouml;bberling type of FPL) based on her physical exam findings (lack of fat in legs and arms and excess fat in her chin and face, as well as belly fat). Her medical problems included &nbsp;diabetes, high levels of fats in the blood, pancreatitis, heart coronary artery disease, high blood pressure, depression, and asthma.&nbsp; She did not improve with any medication, and it was decided that she should do the gastric bypass surgery. On follow-up, she was noted to have lost weight, in her face and abdomen. A year and a half after the procedure, she had lost 30% of her former body weight and her blood pressure was normal. Sixteen months after surgery, her blood fat and her diabetes were well controlled while off all diabetes and lipid medications.[12406]<br />\r\n<span><br />\r\nIn another report, a 28-year-old women diagnosed with familiar partial lipodystrofphy, Dunnigan type, who did not improve with medication had excellent results with the surgery, normalizing the fat stores  and improving all metabolic problems.[12407]&nbsp;<br />\r\n<br />\r\nThese reports concluded that gastric bypass, even when patients are not obese, may be a treatment option for those patients with FPL who have severe metabolic problems that cannot be controlled with medication alone.<br />\r\n</span>","dateModified":"2016-10-20T14:50:00","references":[{"referenceId":12405,"authors":"Handelsman Y & cols","articleTitle":"The Clinical Apporach to the Detection of Lipodystrophy -  An  AACE Consensus Statement","bookWebsiteJournalTitle":"Endocrine practice?: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists","date":"2013","volume":"19(1)","pages":"107-116","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108221/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12406,"authors":"Utzschneider KM & Trence DL","articleTitle":"Effectiveness of gastric bypass surgery in a patient with familial partial lipodystrophy","bookWebsiteJournalTitle":"Diabetes Care","date":"June, 2006","volume":"29(6)","pages":"1380-2","url":"https://www.ncbi.nlm.nih.gov/pubmed/16732025","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12407,"authors":"Ciudin A, Baena-Fustegueras JA, Fort JM, Encabo G, Mesa J & Lecube A","articleTitle":"Successful treatment for the Dunnigan-type familial partial lipodystrophy with Roux-en-Y gastric bypass","bookWebsiteJournalTitle":"Clinical Endocrinology","date":"75","volume":"403–404","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/21521325","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12409,"authors":"McGrath NM  & Krishna G.","articleTitle":"Gastric bypass for insulin resistance due to lipodystrophy","bookWebsiteJournalTitle":"Obes Surg","date":"November, 2006","volume":"16(11)","pages":"1542-4","url":"","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":14182,"phenoTypeName":"Diabetes mellitus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6044,"phenoTypeName":"Hyperinsulinemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6027,"phenoTypeName":"Hypertension","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6024,"phenoTypeName":"Insulin resistance","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6926,"phenoTypeName":"Lipoatrophy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5695,"phenoTypeName":"Hepatic steatosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9740,"phenoTypeName":"Polycystic ovaries","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8272,"phenoTypeName":"Xanthomatosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10285,"phenoTypeName":"Acanthosis nigricans","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9003,"phenoTypeName":"Coronary artery atherosclerosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3874,"phenoTypeName":"Pancreatitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8880,"phenoTypeName":"Abnormality of the musculature","percentRanges":"-"},{"phenoTypeId":3876,"phenoTypeName":"Acute pancreatitis","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":14532,"phenoTypeName":"Hyperglycemia","percentRanges":"-"},{"phenoTypeId":13752,"phenoTypeName":"Hypertriglyceridemia","percentRanges":"-"},{"phenoTypeId":10467,"phenoTypeName":"Increased adipose tissue around the neck","percentRanges":"-"},{"phenoTypeId":9887,"phenoTypeName":"Increased facial adipose tissue","percentRanges":"-"},{"phenoTypeId":3456,"phenoTypeName":"Increased subcutaneous truncal adipose tissue","percentRanges":"-"},{"phenoTypeId":6035,"phenoTypeName":"Insulin-resistant diabetes mellitus","percentRanges":"-"},{"phenoTypeId":12793,"phenoTypeName":"Juvenile onset","percentRanges":"-"},{"phenoTypeId":4960,"phenoTypeName":"Lipodystrophy","percentRanges":"-"},{"phenoTypeId":3463,"phenoTypeName":"Loss of gluteal subcutaneous adipose tissue","percentRanges":"-"},{"phenoTypeId":12796,"phenoTypeName":"Loss of subcutaneous adipose tissue in limbs","percentRanges":"-"},{"phenoTypeId":8295,"phenoTypeName":"Prominent superficial veins","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Familial_partial_lipodystrophy_type_K%C3%B6bberling"}